VASILE, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 5.460
NA - Nord America 5.446
EU - Europa 4.921
SA - Sud America 566
AF - Africa 126
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.543
Nazione #
US - Stati Uniti d'America 5.244
CN - Cina 1.710
SG - Singapore 1.609
IT - Italia 1.177
GB - Regno Unito 1.099
DE - Germania 528
HK - Hong Kong 502
SE - Svezia 458
BR - Brasile 454
RU - Federazione Russa 444
VN - Vietnam 443
IN - India 331
FR - Francia 257
NL - Olanda 222
BD - Bangladesh 181
IE - Irlanda 152
FI - Finlandia 144
TR - Turchia 138
KR - Corea 127
CA - Canada 114
ID - Indonesia 112
JP - Giappone 88
UA - Ucraina 81
DK - Danimarca 74
ES - Italia 61
CI - Costa d'Avorio 44
MX - Messico 41
CH - Svizzera 38
PH - Filippine 38
AR - Argentina 33
EU - Europa 32
BE - Belgio 30
PL - Polonia 27
AT - Austria 25
CO - Colombia 25
TW - Taiwan 25
ZA - Sudafrica 23
AU - Australia 22
PK - Pakistan 19
GR - Grecia 18
IQ - Iraq 17
IR - Iran 17
CZ - Repubblica Ceca 16
RO - Romania 16
UZ - Uzbekistan 15
EC - Ecuador 14
MA - Marocco 14
CL - Cile 13
EG - Egitto 13
VE - Venezuela 11
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
IL - Israele 8
KE - Kenya 8
LV - Lettonia 8
MY - Malesia 8
SA - Arabia Saudita 8
CR - Costa Rica 7
DO - Repubblica Dominicana 7
JO - Giordania 7
LT - Lituania 7
NO - Norvegia 7
LU - Lussemburgo 6
PE - Perù 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
JM - Giamaica 5
NP - Nepal 5
PY - Paraguay 5
SC - Seychelles 5
BO - Bolivia 4
HN - Honduras 4
HR - Croazia 4
KZ - Kazakistan 4
PA - Panama 4
AM - Armenia 3
BB - Barbados 3
CY - Cipro 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
MM - Myanmar 3
PR - Porto Rico 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
CG - Congo 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
MN - Mongolia 2
OM - Oman 2
SI - Slovenia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
Totale 16.559
Città #
Southend 915
Singapore 894
Ashburn 627
Milan 468
Hong Kong 421
Chandler 362
San Jose 330
Dallas 311
Beijing 290
Fairfield 246
Seattle 216
Hefei 207
Council Bluffs 204
Wilmington 196
Princeton 159
Dublin 150
Los Angeles 147
Hanoi 133
Ho Chi Minh City 131
Woodbridge 131
Dearborn 124
Santa Clara 114
Ann Arbor 103
Bengaluru 102
Cambridge 99
Lauterbourg 96
New York 90
Houston 87
Munich 82
Moscow 80
Frankfurt am Main 77
Jakarta 76
Buffalo 69
Helsinki 67
Guangzhou 64
Seoul 63
Des Moines 61
Nanjing 57
Phoenix 56
Mountain View 53
Tokyo 50
São Paulo 49
Shanghai 48
Toronto 48
Boardman 46
Abidjan 44
Redwood City 43
Redmond 42
Istanbul 37
Tianjin 36
Jacksonville 34
Rome 34
Changsha 33
Nuremberg 30
Columbus 29
Jinan 27
Medford 27
Turku 27
Cangzhou 26
Garlasco 25
Naples 25
Da Nang 24
Eitensheim 24
Fremont 24
Shenyang 24
The Dalles 24
Brussels 23
London 23
Andover 22
San Diego 22
Berlin 21
Chicago 21
Montreal 21
Sakarya 21
Shenzhen 21
Warsaw 21
Somerville 20
Amsterdam 19
Atlanta 19
Hangzhou 19
Hebei 19
Mumbai 19
Boston 18
Florence 18
Stockholm 18
Hanover 17
Nanchang 17
Bogotá 16
Kent 16
Orem 16
Serra 16
Taipei 16
Wuhan 16
Chennai 15
Cremona 15
Haiphong 15
Rio de Janeiro 15
Athens 14
Belo Horizonte 14
Denver 14
Totale 9.655
Nome #
NMR interaction studies of Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc with influenza-virus hemagglutinin expressed in transfected human cells 323
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies 315
Comprehensive analysis of blood group antigen binding to classical and El Tor cholera toxin B-pentamers by NMR 310
Insights into the Binding of Cyclic RGD Peptidomimetics to a5b1 Integrin by using Live-Cell NMR And Computational Studies 301
Computer aided design and NMR characterization of an oligopeptide targeting the Ebola virus VP24 protein 295
Peptide Nucleic Acids (PNAs) in STD NMR experiments: a simple and valuable tool for studying HuR-small molecule complexes 265
Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist 263
Synthesis of novel DC-SIGN ligands with an alfa-fucosylamide anchor 255
Hydrogen Bonding in a L-Glutamine-Based Polyamidoamino Acid and its pH-Dependent Self-Ordered Coil Conformation 255
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro 253
Maytansinol Functionalization: Towards Useful Probes for Studying Microtubule Dynamics 240
Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data 240
A Combined NMR-Computational Study of the Interaction between Influenza Virus Hemagglutinin and Sialic Derivatives from Human and Avian Receptors on the Surface of Transfected Cells 234
New homo- and heretodimeric SMAC mimetic compound as apoptosis inducers 228
Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach 223
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 219
New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds 218
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II : Structural and biological characterization 216
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-beta-ACPC) Scaffolds 215
Novel compounds targeting the RNA-binding protein HuR : Structure-based design, synthesis and interaction studies 213
Identification and characterization of folding inhibitors of hen egg lysozyme : an example of a new paradigm of drug design 206
Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 206
Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders 206
An Insight into the Role of Reactant Structure Effect in Pd/C Catalysed Aldehyde Hydrogenation 198
Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia** 198
Total Synthesis of an Epothilone Analogue based on the Amide‒Triazole Bioisosterism 197
A NMR STUDY OF SMAC MIMICS TARGETING BOTH THE BIR2 AND BIR3 DOMAINS IN XIAP PROTEIN. 197
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma 197
Structure revision of the Lantibiotic 97518 195
Design, Synthesis and Biological Evaluation of Novel cRGD-Paclitaxel Conjugates for Integrin-Assisted Drug Delivery 195
Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I : synthesis 194
Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D Inhibition 191
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 190
RGD-based peptides targheting αIIbβ3 and αvβ3 integrin receptors: an NMR point of view 187
Towards the Modulation of RNA-Binding Proteins: New Compounds Targeting Protein HuR 185
A folding inhibitor of the HIV-1 Protease 182
Protein nanocrystallography : Growth mechanism and atomic structure of crystals induced by nanotemplates 182
An integrated computational and NMR study of the first peptidimimetic inhibitors of cadherin homophilic interaction 180
A fragment-based virtual screening approach to identify e-cadherin lingands 178
Chemical and Biophysical Approaches to Allosteric Modulation 178
Identification of New L-Fucosyl and L-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia 177
Binding of RGD-Peptide Mimics to Living Human Cancer Cells: a NMR Study 177
Identification and characterization of folding inhibitors of hen egg Lysozyme : an example of a new paradigm of drug design 176
Tracking the interaction between α-Synuclein mutants and Tubulin Using DOSY (Diffusion Ordered Spectroscopy) NMR 175
Solution structure of the human endostatin fragment EH6-49 by 1-H NMR and molecular dynamics calculations 175
A Comprehensive NMR Analysis of the Interaction between DKP-RGD Ligands and Membrane Proteins on Intact Cells 175
BOPC1 Enantiomers Preparation and HuR Interaction Study : From Molecular Modeling to a Curious DEEP-STD NMR Application 172
Identification of the folding inhibitors of hen-egg lysozyme : gathering the right tools 171
STD and trNOESY NMR Study of Receptor-Ligand Interactions in Living Cancer Cells 170
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 170
Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and αIIbβ3 integrin-rich intact cells by NMR and computational studies 167
Targeting integrins alphaVbeta3 and alphaIIbeta3 with RGD peptidomimetics : study of the ligand conformation and of the ligand-receptor interactions 166
Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space : The Case of Rifampicin 164
Different behavior of cyclic RGD peptidomimetics versus a5b1 and aVb3 integrin-rich cancer cells: NMR and computational analysis 162
Anti-multiple myeloma potential of secondary metabolites from Hibiscus sabdariffa 157
Peptidomimetic inhibitors of cadherin homophilic interactions: from computational design to ligand binding epitope by STD NMR 154
Determination of Structural Ensembles of Flexible Molecules in Solution from NMR Data Undergoing Spin Diffusion 154
Binding of RGD-peptide mimics to intact human platelets : an NMR study 152
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 151
C-5 modification of β-Fucosides as a strategy for targeting the BC2L-C Lectin 149
A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands 149
Both El Tor and classical cholera toxin bind blood group determinants 148
Ligand-target interaction: a NMR point of view 148
STD-NMR experiments on tumor cells to investigate RGD ligand - membrane protein interactions 145
Diffusion-ordered spectroscopy and saturation transfer difference NMR spectroscopy studies of selective interactions between ELAV protein fragments and an mRNA target 144
Cyclic RGD peptidomimetics: insights into the binding to integrin-rich cancer cells by NMR and computational studies 144
Allosteric modulators of Hsp90: design, synthesis and activity evaluation 144
Synthesis of tetrasubstituted nitroalkenes and preliminary studies of their enantioselective organocatalytic reduction. 142
Pt‐WOx/C catalysts for α, β‐ unsaturated aldehydes hydrogenation: a NMR study of the effect of the reactant adsorption on activity and selectivity 142
Synthesis and characterization of new potential tadf photocatalysts 139
Synthesis, Stereochemical and Photophysical Properties of Functionalized Thiahelicenes 136
Targeting a Multidrug-Resistant Pathogen: First Generation Antagonists of Burkholderia cenocepacia's BC2L-C Lectin 135
C-5 edited β-Fucosides Targeting the BC2L-C Lectin of B. cenocepacia 134
Highly Conjugated Bis(benzo[b]phosphole)‐P‐oxides: Synthesis and Electrochemical, Optical, and Computational Studies 133
STD NMR with Peptide Nucleic Acids (PNA): An Innovative Approach to Studying HuR - Small molecule interactions 133
Solution structure by nuclear magnetic resonance of the two lantibiotics 97518 and NAI-107 132
Self-structuring of main-chain and pH-dependent conformation of L-glutaminebased polyamidoamino acid: a molecular dynamics study 130
Lantibiotic carboxyamide derivatives with enhanced antibacterial activity 126
Benzofuran Derivatives Activators of the Chaperone Protein Hsp90: Synthesis, Interaction Studies and Biological Effects 124
Targeting the RelSeq Synthetase Domain with Amino Benzoic Acid Centred Inhibitors 122
Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling 118
Investigating the interaction of peptidomimetic ligands with e-cadherin using NMR and computational studies 118
Acid-base and lipophilic properties of peptide nucleic acid derivatives 117
Exploring small molecules as RNA-RBPs (RNA-Binding Proteins) modulators: the use of PNA in competition studies 115
Stability of compounded nivolumab solution after pneumatic system transportation 115
Identification of HuR-RNA Interfering Compounds by Dynamic Combinatorial Chemistry and Fluorescence Polarization 111
NMR as a Powerful Tool for Identifying Natural Compounds Able to Interfere with ELAV-mRNA Complexes 110
Analyzing the interaction between RNA and RBPs (RNA-binding proteins) by NMR spectroscopy: the introduction of small molecules as third wheel 103
Novel Glycomimetics as First Antagonists of Burkholderia Cenocepacia Lectin BC2L-C-Nt: Design and Synthesis of β-C- and β-N-fucosides 101
Biophysical Assays for Investigating Modulators of Macromolecular Complexes: An Overview 100
Structure-based design of RelSeq inhibitors: growth of an amino benzoic acid fragment 94
Solution structure of the β-subunit of the translation initiation factor aIF2 from archaebacteria Sulfolobus solfataricus 93
Synthesis and characterization of Hsp90 allosteric activators 92
Crystallization of alpha and beta subunits of IF2 translation initiation factor from archaebacteria Sulfolobus solfataricus 88
Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc 87
Novel β-C and β-N fucosides as first synthetic ligands for BC2L-C N-term lectin from B. cenocepacia 83
Chiral 2-phenyl-3-hydroxypropyl esters as PKC-alpha modulators: HPLC enantioseparation, NMR absolute configuration assignment, and molecular docking studies 75
Influence of allosteric Hsp90 ATPase activators on its chaperoning activity 74
Novel Glycomimetic Ligands for Bacterial Lectins: Design, Synthesis and Biophysical Evaluation 73
Structural investigation of proapoptotic peptide by CD and NMR spectroscopy 64
Totale 16.918
Categoria #
all - tutte 49.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 0 105 40
2021/2022975 86 48 27 33 63 98 82 63 92 69 86 228
2022/20231.411 168 119 127 128 159 237 27 124 172 31 70 49
2023/2024854 31 55 41 55 191 63 42 55 36 59 105 121
2024/20252.942 118 252 58 212 238 154 194 279 150 322 329 636
2025/20266.389 624 707 711 608 563 355 812 325 680 429 575 0
Totale 17.295